MKI67 and prostate cancer: Notably, our observation of three patients with SUVmax exceeding 7.67 and standard ADC below 0.0013 being classified as high-risk suggests the potential utility of integrating standard ADC and SUVmax for more accurate prediction of Ki-67 expression in prostate cancer.